[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Longuemare et al., 1995 - Google Patents

Excitatory amino acid release from astrocytes during energy failure by reversal of sodium‐dependent uptake

Longuemare et al., 1995

Document ID
1303763968124036085
Author
Longuemare M
Swanson R
Publication year
Publication venue
Journal of neuroscience research

External Links

Snippet

Non‐synaptic release may be the major route of excitatory amino acid (EAA) efflux during cerebral ischemia. Possible routes of non‐synaptic release include non‐specific anion channels, reversal of Na+‐, CI−‐, or Ca2+‐dependent uptake, and cell lysis. In the present …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Similar Documents

Publication Publication Date Title
Longuemare et al. Excitatory amino acid release from astrocytes during energy failure by reversal of sodium‐dependent uptake
Birka et al. Enhanced susceptibility to erythrocyte “apoptosis” following phosphate depletion
Tekkök et al. Transfer of glycogen‐derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity
Puro Diabetes-induced dysfunction of retinal Müller cells.
Longuemare et al. K+-induced reversal of astrocyte glutamate uptake is limited by compensatory changes in intracellular Na+
Ye et al. Functional hemichannels in astrocytes: a novel mechanism of glutamate release
Ros et al. Lactate reduces glutamate‐induced neurotoxicity in rat cortex
Swanson et al. Fluorocitrate and fluoroacetate effects on astrocyte metabolism in vitro
Egger et al. Coincidence detection and changes of synaptic efficacy in spiny stellate neurons in rat barrel cortex
Anderson et al. The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions
Overstreet et al. Glutamate transporters contribute to the time course of synaptic transmission in cerebellar granule cells
Vaz et al. Bilirubin selectively inhibits cytochrome c oxidase activity and induces apoptosis in immature cortical neurons: assessment of the protective effects of glycoursodeoxycholic acid
Lang et al. Cation channels, cell volume and the death of an erythrocyte
del Cerro et al. Stimulation of NMDA receptors activates calpain in cultured hippocampal slices
Anderson et al. Differing effects of substrate and non‐substrate transport inhibitors on glutamate uptake reversal
MITSUYAMA et al. Uptake and antioxidant effects of ergothioneine in human erythrocytes
Ringel et al. Contribution of anion transporters to the acidosis‐induced swelling and intracellular acidification of glial cells
Fraser et al. Calcium transport abnormality in uremic rat brain synaptosomes.
Singh et al. Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway
Olson et al. Increased potassium, chloride, and taurine conductances in astrocytes during hypoosmotic swelling
Parker et al. Ascorbic acid transport in brain microvascular pericytes
Maycotte et al. Apoptosis and autophagy in rat cerebellar granule neuron death: Role of reactive oxygen species
Apricò et al. Binding and transport of [3H](2S, 4R)‐4‐methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes
Ling et al. Prostaglandin E2 activates clusters of apical Cl-channels in principal cells via a cyclic adenosine monophosphate-dependent pathway.
Rochat et al. N‐acetylcysteine inhibits Na+ absorption across human nasal epithelial cells